{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T01:06:05Z","timestamp":1779066365298,"version":"3.51.4"},"reference-count":0,"publisher":"Japan Medical Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMA J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.31662\/jmaj.2026-0045","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:07:05Z","timestamp":1779062825000},"source":"Crossref","is-referenced-by-count":0,"title":["Triplet Therapy (Androgen Deprivation Therapy + Darolutamide + Biweekly Docetaxel) for High-risk Metastatic Castration-sensitive Prostate Cancer (TRIC Study): A Study Protocol for Open-labelled Single-Arm Phase II Clinical Trial"],"prefix":"10.31662","volume":"9","member":"16605","container-title":["JMA Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmaj.jp\/download.php?id=10.31662\/jmaj.2026-0045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:07:07Z","timestamp":1779062827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmaj.jp\/detail.php?id=10.31662\/jmaj.2026-0045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":0,"journal-issue":{"issue":"4"},"alternative-id":["jmaj.2026-0045"],"URL":"https:\/\/doi.org\/10.31662\/jmaj.2026-0045","relation":{},"ISSN":["2433-3298","2433-328X"],"issn-type":[{"value":"2433-3298","type":"electronic"},{"value":"2433-328X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}